Trial Details
COMPLETEDBasic Information
| Clinical ID | c4016 |
|---|---|
| Identifier | NCT01177228 |
| Trial Title | Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Vedolizumab|DRUG: Placebo |
Participant Information
| Sponsor | Millennium Pharmaceuticals, Inc. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2007-05 |
|---|---|
| Primary Completion Date | 2008-06 |
| Completion Date | 2008-09 |